Cargando…
Survivin, Survivin-2B, and Survivin-deItaEx3 expression in medulloblastoma: biologic markers of tumour morphology and clinical outcome
Survivin is an apoptotic inhibitor that is expressed at high levels in a variety of malignancies. Survivin has four known alternative splice forms (Survivin, Survivin-2B, Survivin-deltaEx3, and Survivin-3B), and the recent literature suggests that these splice variants have unique functions and subc...
Autores principales: | Fangusaro, J R, Jiang, Y, Holloway, M P, Caldas, H, Singh, V, Boué, D R, Hayes, J, Altura, R A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361849/ https://www.ncbi.nlm.nih.gov/pubmed/15655550 http://dx.doi.org/10.1038/sj.bjc.6602317 |
Ejemplares similares
-
Expression of survivin and its splice variants survivin-2B and survivin-ΔEx3 in breast cancer
por: Ryan, B, et al.
Publicado: (2005) -
Nuclear expression of Survivin in paediatric ependymomas and choroid plexus tumours correlates with morphologic tumour grade
por: Altura, R A, et al.
Publicado: (2003) -
Survivin 2α: a novel Survivin splice variant expressed in human malignancies
por: Caldas, Hugo, et al.
Publicado: (2005) -
Expression of cytoplasmic and nuclear Survivin in primary and secondary human glioblastoma
por: Xie, D, et al.
Publicado: (2006) -
Expression of nuclear survivin in normal skin and squamous cell carcinoma: a possible role in tumour invasion
por: Dallaglio, K, et al.
Publicado: (2014)